2b3l: Difference between revisions

From Proteopedia
Jump to navigation Jump to search
No edit summary
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
Determination of the crystal structure of human MetAP1 makes it possible, for the first time, to compare the structures of a Type I and a Type II, methionine aminopeptidase (MetAP) from the same organism. Comparison of, the Type I enzyme with the previously reported complex of ovalicin with, Type II MetAP shows that the active site of the former is reduced in size, and would incur steric clashes with the bound inhibitor. This explains why, ovalicin and related anti-angiogenesis inhibitors target Type II human, MetAP but not Type I. The differences in both size and shape of the active, sites between MetAP1 and MetAP2 also help to explain their different, substrate specificity. In the presence of excess Co(2+), a third cobalt, ion binds in the active site region, explaining why metal ions in excess, can be inhibitory. Also, the N-terminal region of the protein contains, three distinct Pro-x-x-Pro motifs, supporting the prior suggestion that, this region of the protein may participate in binding to the ribosome.
Determination of the crystal structure of human MetAP1 makes it possible, for the first time, to compare the structures of a Type I and a Type II methionine aminopeptidase (MetAP) from the same organism. Comparison of the Type I enzyme with the previously reported complex of ovalicin with Type II MetAP shows that the active site of the former is reduced in size and would incur steric clashes with the bound inhibitor. This explains why ovalicin and related anti-angiogenesis inhibitors target Type II human MetAP but not Type I. The differences in both size and shape of the active sites between MetAP1 and MetAP2 also help to explain their different substrate specificity. In the presence of excess Co(2+), a third cobalt ion binds in the active site region, explaining why metal ions in excess can be inhibitory. Also, the N-terminal region of the protein contains three distinct Pro-x-x-Pro motifs, supporting the prior suggestion that this region of the protein may participate in binding to the ribosome.


==About this Structure==
==About this Structure==
Line 16: Line 16:
[[Category: Addlagatta, A.]]
[[Category: Addlagatta, A.]]
[[Category: Hu, X.]]
[[Category: Hu, X.]]
[[Category: Liu, J.O.]]
[[Category: Liu, J O.]]
[[Category: Matthews, B.W.]]
[[Category: Matthews, B W.]]
[[Category: ACY]]
[[Category: ACY]]
[[Category: GOL]]
[[Category: GOL]]
Line 27: Line 27:
[[Category: pitabread fold]]
[[Category: pitabread fold]]


''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri Feb 15 17:15:27 2008''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 16:33:47 2008''

Revision as of 17:33, 21 February 2008

File:2b3l.jpg


2b3l, resolution 1.5Å

Drag the structure with the mouse to rotate

Crystal structure of type I human methionine aminopeptidase in the apo form

OverviewOverview

Determination of the crystal structure of human MetAP1 makes it possible, for the first time, to compare the structures of a Type I and a Type II methionine aminopeptidase (MetAP) from the same organism. Comparison of the Type I enzyme with the previously reported complex of ovalicin with Type II MetAP shows that the active site of the former is reduced in size and would incur steric clashes with the bound inhibitor. This explains why ovalicin and related anti-angiogenesis inhibitors target Type II human MetAP but not Type I. The differences in both size and shape of the active sites between MetAP1 and MetAP2 also help to explain their different substrate specificity. In the presence of excess Co(2+), a third cobalt ion binds in the active site region, explaining why metal ions in excess can be inhibitory. Also, the N-terminal region of the protein contains three distinct Pro-x-x-Pro motifs, supporting the prior suggestion that this region of the protein may participate in binding to the ribosome.

About this StructureAbout this Structure

2B3L is a Single protein structure of sequence from Homo sapiens with , and as ligands. Active as Methionyl aminopeptidase, with EC number 3.4.11.18 Full crystallographic information is available from OCA.

ReferenceReference

Structural basis for the functional differences between type I and type II human methionine aminopeptidases., Addlagatta A, Hu X, Liu JO, Matthews BW, Biochemistry. 2005 Nov 15;44(45):14741-9. PMID:16274222

Page seeded by OCA on Thu Feb 21 16:33:47 2008

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA